Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119687656 | 11968765 | 6 | F | 20141208 | 20160822 | 20160128 | 20160824 | EXP | CA-ROCHE-1219752 | ROCHE | 40.53 | YR | M | Y | 58.00000 | KG | 20160824 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119687656 | 11968765 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | B2033B20,B2028B10,B2047B07,B2035,B2 | 125276 | 536 | MG | SOLUTION FOR INFUSION | ||||||
| 119687656 | 11968765 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | B2033B20,B2028B10,B2047B07,B2035,B2 | 125276 | 576 | MG | SOLUTION FOR INFUSION | ||||||
| 119687656 | 11968765 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | B2033B20,B2028B10,B2047B07,B2035,B2 | 125276 | 504 | MG | SOLUTION FOR INFUSION | ||||||
| 119687656 | 11968765 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | B2033B20,B2028B10,B2047B07,B2035,B2 | 125276 | 480 | MG | SOLUTION FOR INFUSION | ||||||
| 119687656 | 11968765 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | B2033B20,B2028B10,B2047B07,B2035,B2 | 125276 | 464 | MG | SOLUTION FOR INFUSION | ||||||
| 119687656 | 11968765 | 6 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | B2033B20,B2028B10,B2047B07,B2035,B2 | 125276 | 220 | MG | SOLUTION FOR INFUSION | ||||||
| 119687656 | 11968765 | 7 | C | TACROLIMUS. | TACROLIMUS | 1 | 0 | ||||||||||||
| 119687656 | 11968765 | 8 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 119687656 | 11968765 | 9 | C | 30/70 INSULIN | 2 | 0 | |||||||||||||
| 119687656 | 11968765 | 10 | C | MORPHINE | MORPHINE | 1 | 0 | ||||||||||||
| 119687656 | 11968765 | 11 | C | COD LIVER PILL | 2 | 0 | |||||||||||||
| 119687656 | 11968765 | 12 | C | MARIJUANA | CANNABIS SATIVA SUBSP. INDICA TOP | 1 | 0 | ||||||||||||
| 119687656 | 11968765 | 13 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 119687656 | 11968765 | 14 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 119687656 | 11968765 | 15 | C | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | 0 | ||||||||||||
| 119687656 | 11968765 | 16 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Unknown | 0 | 1 | MG | Q6H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119687656 | 11968765 | 1 | Still's disease adult onset |
| 119687656 | 11968765 | 2 | Off label use |
| 119687656 | 11968765 | 7 | Immunosuppression |
| 119687656 | 11968765 | 14 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119687656 | 11968765 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119687656 | 11968765 | Allergy to plants | |
| 119687656 | 11968765 | Blood cholesterol increased | |
| 119687656 | 11968765 | Blood creatinine increased | |
| 119687656 | 11968765 | Blood pressure diastolic decreased | |
| 119687656 | 11968765 | Blood pressure systolic increased | |
| 119687656 | 11968765 | Dental caries | |
| 119687656 | 11968765 | Dizziness postural | |
| 119687656 | 11968765 | Heart rate decreased | |
| 119687656 | 11968765 | Heart rate increased | |
| 119687656 | 11968765 | Hunger | |
| 119687656 | 11968765 | Inflammation | |
| 119687656 | 11968765 | Influenza | |
| 119687656 | 11968765 | Joint injury | |
| 119687656 | 11968765 | Joint swelling | |
| 119687656 | 11968765 | Ligament sprain | |
| 119687656 | 11968765 | Mean cell haemoglobin increased | |
| 119687656 | 11968765 | Mean cell volume increased | |
| 119687656 | 11968765 | Muscle strain | |
| 119687656 | 11968765 | Neutrophil count decreased | |
| 119687656 | 11968765 | Off label use | |
| 119687656 | 11968765 | Pain | |
| 119687656 | 11968765 | Pain in extremity | |
| 119687656 | 11968765 | Peripheral swelling | |
| 119687656 | 11968765 | Pneumonia | |
| 119687656 | 11968765 | Rash pustular | |
| 119687656 | 11968765 | Weight decreased | |
| 119687656 | 11968765 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119687656 | 11968765 | 1 | 20111209 | 0 | ||
| 119687656 | 11968765 | 2 | 20130305 | 0 | ||
| 119687656 | 11968765 | 3 | 20130523 | 0 | ||
| 119687656 | 11968765 | 4 | 20140108 | 0 | ||
| 119687656 | 11968765 | 5 | 20150223 | 0 | ||
| 119687656 | 11968765 | 6 | 20150727 | 0 |